Fact-checked by Grok 2 weeks ago

Alcohol intolerance

Alcohol intolerance is a metabolic disorder, often genetic, in which the body cannot efficiently break down alcohol due to deficiencies in enzymes responsible for its metabolism, resulting in the rapid accumulation of acetaldehyde—a toxic byproduct that triggers immediate and unpleasant physical reactions even after consuming small amounts of alcohol. The genetic form is primarily caused by variants in the ALDH2 gene, which impairs the aldehyde dehydrogenase enzyme, though acquired causes such as certain medications or diseases can also lead to the condition; it results in symptoms such as facial flushing (a warm, red appearance on the face, neck, and chest), nausea, stuffy nose, rapid heartbeat, headache, and dizziness, often occurring within minutes of alcohol ingestion. Unlike a true alcohol allergy, which is a rare immune-mediated response to or its ingredients (causing , swelling, or severe abdominal cramps), alcohol intolerance is not an allergic reaction but a metabolic one, and it does not involve production against alcohol itself. The condition is most prevalent among individuals of East Asian descent, affecting 30% to 50% of this population due to the high frequency of the *2 allele, though it can occur in people of any ethnicity. Prolonged exposure to from alcohol intolerance elevates the risk of esophageal and other cancers, as this substance is a known , underscoring the importance of avoidance for long-term health. There is no cure, and management relies on complete from , with diagnostic confirmation often based on symptom history or an ethanol that induces localized flushing.

Clinical Manifestations

Signs and Symptoms

Alcohol intolerance is characterized by immediate, observable physical reactions following consumption, primarily due to inefficient leading to accumulation. Typical acute symptoms include facial flushing or reddening of the skin, or runny nose, rapid heartbeat (), , , and . These manifestations often occur even with small amounts of and can be accompanied by additional signs such as , low , or stomach pain. Symptoms generally begin within minutes to an hour after , reflecting the rapid buildup of unmetabolized byproducts, and typically resolve within 1 to 3 hours without additional exposure as the body processes the . The timing and persistence can vary based on factors like the type of beverage and concurrent health conditions, such as , which may exacerbate respiratory symptoms. The intensity of these reactions depends on the quantity of ingested and the individual's inherent sensitivity, with even modest intake triggering severe discomfort in highly susceptible people. For example, often provokes stronger responses compared to other alcohols due to its elevated levels, which can amplify flushing and gastrointestinal upset. A well-known example is the "Asian flush" reaction, involving marked facial and upper-body flushing, which was first documented in medical literature in the 1970s through studies on ethnic variations in alcohol metabolism among East Asian populations. This manifestation affects up to 50% of individuals of East Asian descent and serves as a classic indicator of alcohol intolerance.

Associated Complications

Individuals with alcohol intolerance, particularly those with deficiency leading to chronic exposure, face an elevated risk of esophageal and other upper aerodigestive tract cancers. Epidemiological studies indicate that ALDH2 heterozygotes experience approximately 12 times higher relative hazard for these cancers compared to those with fully active ALDH2, with odds ratios ranging from 3.7 to 18.1 overall and exceeding 10 for heavy drinkers. Unmanaged alcohol intolerance can contribute to esophageal motility disorders and (GERD). Ethanol consumption, even in those with intolerance, disrupts esophageal , potentially leading to conditions like characterized by high-amplitude contractions. Additionally, the alcohol flushing response serves as a significant for reflux , with an adjusted of 1.18, and for , with an adjusted of 1.32. Repeated flushing episodes associated with alcohol intolerance impose cardiovascular strain through and . The genetic variant causing impaired alcohol metabolism, common in flushing, promotes and damage, increasing the overall risk of heart disease. In rare cases, alcohol intolerance may precipitate severe anaphylactoid reactions, manifesting as urticaria, , and respiratory distress. These can progress to and syncope due to vasodilatory effects and low . The visible symptoms of alcohol intolerance, such as facial flushing, can lead to psychological complications including and avoidance behaviors in social settings involving alcohol. Individuals may experience heightened embarrassment and anxiety from these reactions, prompting reduced participation in social activities to evade scrutiny.

Pathophysiology

Metabolic Pathways

Alcohol metabolism primarily occurs in the liver through oxidative pathways, where is first converted to by (ADH) enzymes, and then is further oxidized to by aldehyde dehydrogenase (ALDH) enzymes. This two-step process accounts for over 90% of elimination in the body, with the reactions being NAD+-dependent and occurring mainly in the for ADH and mitochondria for ALDH2, the predominant isoform. The overall pathway is crucial for , but disruptions can lead to the accumulation of toxic intermediates. Acetaldehyde, the intermediary product, is highly reactive and toxic, responsible for many symptoms of alcohol intolerance, including facial flushing, nausea, and tachycardia due to its vasodilatory effects on blood vessels. Additionally, acetaldehyde forms DNA adducts that contribute to its carcinogenic properties, increasing risks for cancers such as esophageal carcinoma when levels build up. In individuals with impaired metabolism, even moderate ethanol intake can elevate acetaldehyde concentrations significantly, exacerbating these effects. Several isoforms of ADH and ALDH exist, with variations influencing the rate of alcohol metabolism; for instance, class I ADH (including ADH1B) and mitochondrial ALDH2 are central to this process in humans. ADH1B isoforms exhibit kinetic properties suited to low ethanol concentrations, with Km values for ethanol typically in the range of 0.05–2 mM, allowing efficient catalysis near physiological levels. ALDH2, particularly, has a low Km for acetaldehyde (around 0.2 μM), enabling rapid clearance, but reduced activity in certain variants slows this step, promoting acetaldehyde buildup. Both ADH and ALDH reactions require NAD+ as a cofactor, which is reduced to NADH during oxidation, potentially leading to cellular imbalances if NAD+ availability is limited. Deficiencies in NAD+ regeneration, often from excessive load or nutritional factors, can inhibit these enzymes, causing further accumulation of or and intensifying intolerance symptoms. Specific genetic mutations in ADH1B and genes can alter these isoform activities, as detailed in related mechanisms.

Genetic and Epigenetic Mechanisms

Alcohol intolerance arises primarily from genetic variations that disrupt the metabolism of and its toxic byproduct, , leading to its accumulation and adverse reactions. The most well-characterized genetic factor is the 2 , defined by the rs671 (SNP), which substitutes for at position 504 (Glu504Lys) in the 2 () enzyme. This mitochondrial enzyme is crucial for oxidizing to ; the variant exerts a dominant-negative effect, reducing catalytic activity by 60–80% in heterozygous carriers (ALDH21/*2) compared to wild-type homozygotes. The *2 is highly prevalent among East Asian populations, affecting approximately 36% or 560 million individuals, and its carriers experience pronounced intolerance symptoms like facial flushing, , and due to elevated levels following alcohol consumption. Another key variant, ADH1B2 (rs1229984, Arg48His) in the alcohol dehydrogenase 1B (ADH1B) gene, encodes a more efficient that accelerates the conversion of to , thereby increasing its production rate by up to 40-fold relative to the wild-type ADH1B1. While ADH1B*2 alone confers protection against by deterring heavy drinking through mild intolerance, its effects are amplified in combination with *2. —carrying one copy of each variant—results in a synergistic buildup of , as rapid generation overwhelms the impaired detoxification, leading to heightened sensitivity, more intense flushing, and gastrointestinal distress even at low alcohol doses. This gene-gene interaction has been demonstrated in Asian American cohorts, where individuals with both variants report significantly more severe low-dose reactions than those with either alone. Epigenetic modifications further modulate these genetic risks by altering ALDH2 expression without changing the DNA sequence. Chronic alcohol exposure promotes hypermethylation at the ALDH2 promoter, a process that silences gene transcription and reduces enzyme levels, exacerbating acetaldehyde accumulation and intolerance in susceptible individuals. Additionally, prolonged ethanol intake disrupts histone acetylation dynamics; alcohol metabolism elevates the NADH/NAD+ ratio, inhibiting SIRT1 (a NAD+-dependent deacetylase) and increasing acetate-derived acetyl-CoA availability for histone acetyltransferases (HATs), resulting in hyperacetylation of histones associated with alcohol metabolism genes like ALDH2. These changes can perpetuate a cycle of impaired metabolism and heightened sensitivity. Genome-wide association studies (GWAS) conducted through 2023 have expanded understanding by identifying additional loci influencing metabolism and intolerance beyond and ADH1B. For instance, variants in the , including ADH7 (which encodes an active in the for initial oxidation), have been linked to altered exposure and reduced consumption, serving as proxies for intolerance risk in multi-ancestry analyses of over 1 million individuals. These findings highlight polygenic contributions, with ADH7 variants contributing to metabolic inefficiency in non-East Asian populations as well. A 2024 whole study in a population further identified rare variants in ADH1C, ADH1A, and ADH5, along with novel genes such as GIGYF1 associated with consumption and sensitivity, underscoring ongoing polygenic influences on intolerance.

Epidemiology

Prevalence and Demographics

Alcohol intolerance exhibits significant variation in prevalence across global populations, largely driven by genetic factors such as the *2 variant. This variant, which impairs activity, affects approximately 8% of the world's population, equating to around 560 million individuals, with the highest concentrations in East Asian groups where carrier rates range from 28% to 45%, leading to intolerance in 30-50% of affected individuals. In contrast, prevalence is much lower among populations, where adverse reactions such as facial flushing occur in only 3-29% of individuals, often below 5% for clinically significant intolerance. Demographic patterns further influence the occurrence of alcohol intolerance. While the genetic prevalence is similar across genders, females may experience more pronounced symptoms attributed to physiological differences including lower body mass, reduced total body water, and decreased activity of alcohol-metabolizing enzymes like alcohol dehydrogenase, resulting in elevated blood alcohol concentrations from equivalent intake. Age also plays a role, with sensitivity to alcohol, including intolerance symptoms, increasing in older adults due to age-related declines in liver function and enzyme efficiency, which impair alcohol metabolism and heighten reactions even among those without genetic predispositions. Incidence of non-genetic, acquired alcohol intolerance remains lower than hereditary forms, often emerging later in life from factors like interactions or damage, though comprehensive studies indicate it affects a minority of the over their lifetime. Underreporting complicates accurate estimates, particularly due to cultural surrounding alcohol-related issues, which discourages disclosure in surveys; data highlight substantial gaps in reporting from low-income regions, where limited healthcare access and social taboos exacerbate underestimation.

Geographic Variations

Alcohol intolerance exhibits marked geographic variations, primarily driven by differences in the prevalence of genetic variants such as , which impairs activity and leads to accumulation after alcohol consumption. In East Asian populations, the allele frequency reaches approximately 30-40%, resulting in carrier rates of 45% among and up to 50% among individuals, contributing to high intolerance rates in these groups. This variant likely arose and spread rapidly 2,000-3,000 years ago under historical selection pressures, including adaptation to agriculture and pathogen exposure during the transition in the region. In contrast, the is rare outside , with carrier frequencies under 5% in and populations, where alcohol intolerance is correspondingly low and more often linked to other factors. Emerging research on admixed populations in the , particularly Latin American groups with partial East Asian ancestry, indicates intermediate allele frequencies around 10%, leading to elevated intolerance compared to non-admixed or -descended groups. Acquired forms of alcohol intolerance also show regional patterns, such as increased disulfiram-like reactions in Southeast Asian areas with high industrial exposure to chemicals like carbon disulfide, used in rayon production, which inhibits ALDH and exacerbates symptoms upon alcohol intake. Among East Asian diaspora communities, such as Chinese-Americans, the high prevalence of ALDH22 persists, maintaining similar intolerance rates despite migration, though cultural and environmental shifts may influence expression and reporting of symptoms. These patterns underscore the role of genetic variants like ALDH22 in shaping regional differences, as detailed in the pathophysiology section.

Etiology and Risk Factors

Inherited Causes

Alcohol intolerance often stems from heritable variants in genes involved in alcohol metabolism, particularly those encoding alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) enzymes, which follow autosomal inheritance patterns. The most prominent example is the ALDH22 allele (rs671), a missense mutation in the ALDH2 gene that produces an enzymatically inactive subunit, exerting a dominant-negative effect on mitochondrial ALDH2 activity. This leads to impaired oxidation of acetaldehyde to acetate, resulting in its toxic accumulation and characteristic symptoms like facial flushing and nausea following alcohol ingestion. The dominance of ALDH22 is evident even in heterozygous individuals, though incomplete penetrance occurs due to factors such as environmental influences and gene dosage effects, meaning not all carriers exhibit severe reactions. Similarly, variants in the ADH1B gene, such as ADH1B*2 (rs1229984), enhance ADH activity, accelerating conversion to and amplifying intolerance, especially in combination with *2. These ADH1B variants exhibit codominant inheritance, where homozygous carriers show the strongest effects, contributing to a polygenic interplay that heightens sensitivity in affected lineages. Family studies underscore the of these traits; for instance, research in East Asian cohorts has estimated the SNP of the at approximately 12.6% among drinkers, with much of this variance explained by *2 and ADH1B variants, indicating substantial familial aggregation. Epigenetic modifications, such as DNA methylation at ALDH2 and ADH loci, can modulate the expression of these inherited variants, influencing intolerance penetrance across generations.

Acquired Causes

Liver diseases, such as cirrhosis, can lead to acquired alcohol intolerance by impairing hepatic function and reducing aldehyde dehydrogenase (ALDH) activity, resulting in acetaldehyde accumulation and symptoms like flushing, nausea, and rapid heartbeat. In patients with chronic liver damage from conditions like viral hepatitis, the onset of intolerance has been documented in clinical cases where liver enzyme deficiencies compromise alcohol detoxification, often manifesting after acute episodes of inflammation. Certain medications induce alcohol intolerance through direct inhibition of ALDH, mimicking or exacerbating acetaldehyde buildup. Disulfiram, used in alcohol aversion therapy, irreversibly blocks ALDH, leading to severe reactions including hypotension and vomiting upon alcohol ingestion. Similarly, metronidazole can produce a disulfiram-like reaction by inhibiting ALDH, though some studies question the consistency of this effect in controlled settings. Infections, particularly Hodgkin's lymphoma, are associated with a specific form of alcohol intolerance characterized by acute pain in enlarged lymph nodes shortly after drinking, reported in 1.5% to 5% of cases. The mechanism remains unclear but may involve ethanol-induced vasodilation in lymph node capsules or prostaglandin release, with symptoms often resolving after chemotherapy achieves remission. Endocrine disorders can also contribute by disrupting hormonal regulation of metabolism, potentially altering alcohol processing, though direct links are less well-established. Post-2023 research has highlighted the role of gut microbiome , often induced by , in increasing production from unabsorbed alcohol by certain , thereby heightening intolerance symptoms like and gastrointestinal distress. For instance, antibiotic disruption of microbial balance reduces protective species, allowing -generating to predominate and elevate systemic levels. These acquired factors primarily impair metabolic pathways by hindering ALDH function or introducing exogenous sources.

Modifiable Risk Factors

Concurrent use represents a key modifiable that exacerbates alcohol intolerance by inducing the 2E1 () enzyme, which accelerates the conversion of to , thereby elevating levels and intensifying symptoms such as facial flushing and . This induction occurs through nicotine's effects on hepatic and enzymes, leading to greater accumulation of the toxic even at moderate doses. Recent epidemiologic research indicates that current smokers, particularly those with substantial exposure, face a substantially higher likelihood of experiencing alcohol flushing, with adjusted ratios around 1.9 compared to non-smokers. Dietary choices involving high-histamine foods, such as aged cheeses (e.g., cheddar or ), can worsen alcohol intolerance symptoms in susceptible individuals by compounding histamine-mediated reactions, including , gastrointestinal distress, and skin flushing. consumption itself promotes release from mast cells or inhibits (DAO), the enzyme that degrades , creating a synergistic effect that amplifies intolerance when combined with histamine-rich meals. This interaction is particularly relevant for those with underlying histamine sensitivity, where even small amounts of such foods prior to drinking can heighten overall symptom severity. Occupational exposures to industrial solvents like N,N-dimethylformamide (DMF), commonly encountered in processes such as synthetic or fiber production, inhibit , resulting in buildup and acute alcohol intolerance manifestations like chest tightness and rapid heartbeat. This enzymatic inhibition mimics disulfiram-like effects, occurring even at low airborne concentrations below occupational limits, and underscores the need for awareness in high-risk work environments. Psychosocial and physiological factors, including and hormonal fluctuations during the , further modulate the intensity of alcohol intolerance symptoms by altering metabolic sensitivity and inflammatory responses. enhances ethanol-induced behavioral effects, such as hypnosis and motor impairment, potentially through heightened reactivity. In women, elevated levels during the late of the increase sensitivity to alcohol's disinhibiting actions, leading to more pronounced symptoms like or flushing at equivalent doses compared to other cycle phases. These modulations highlight how lifestyle stressors and endogenous hormonal shifts can variably amplify intolerance without altering baseline deficiencies.

Diagnosis

Clinical Evaluation

The clinical evaluation of suspected alcohol intolerance begins with a detailed patient history to identify patterns of adverse reactions to consumption. Clinicians inquire about the onset and timing of symptoms, which typically occur shortly after , such as within minutes to hours, distinguishing acute intolerance from delayed responses. Specific questions focus on the types and amounts of alcoholic beverages that trigger reactions—for instance, whether symptoms arise more prominently with fermented drinks like or wine compared to distilled spirits—as well as the severity and duration of episodes. Family history is also assessed, given the genetic basis of many cases, particularly variants in the gene prevalent in East Asian populations. Additionally, healthcare providers explore any use of antihistamines or other remedies and their effectiveness in mitigating symptoms. A follows to corroborate historical reports and detect observable signs, particularly if the patient has recently consumed . Common findings include persistent facial, neck, or chest flushing, warmth, and due to , as well as or elevated , which may persist beyond the immediate post-ingestion period. These signs help gauge the intensity of the reaction but are often transient, emphasizing the reliance on history for . Standardized questionnaires aid in objectively grading the severity of alcohol-induced flushing, a hallmark of intolerance. The flushing , consisting of targeted questions such as whether facial flushing occurs after consuming a (e.g., 180 ml of ) and if it persists beyond the initial 1-2 years of drinking, demonstrates high (88-90%) and specificity (88-92%) for identifying underlying deficiencies. This tool facilitates risk stratification without invasive measures. Red flags during evaluation that warrant prompt referral include symptoms suggestive of underlying , such as persistent , unexplained , or hoarseness alongside flushing, as alcohol intolerance—particularly the flushing response—synergistically increases the risk of esophageal in heavy drinkers (odds ratios 3.7-18.1). In such cases, consultation for endoscopic screening is recommended to rule out precancerous lesions.

Diagnostic Tests

The diagnosis of alcohol intolerance often relies on objective tests that assess metabolic impairments or genetic predispositions, particularly focusing on aldehyde dehydrogenase 2 () deficiency. These methods provide confirmatory evidence beyond clinical symptoms, targeting the accumulation of , a toxic metabolite of . One common diagnostic approach is the patch test, a non-invasive test that simulates the flushing response associated with ALDH2 deficiency. In this procedure, 70% is applied to a lint pad and taped to the inner upper arm for approximately 7-10 minutes, after which the pad is removed and the site is observed for (redness) measuring at least 15 mm in diameter, typically within 5-15 minutes post-removal. This reaction indicates reduced ALDH2 activity, with visual inspection yielding a of about 82% and specificity of 97% for detecting the ALDH2*2 , while advanced hue-saturation-value (HSV) image analysis improves to approximately 86%. The test's positive result stems from local buildup mimicking systemic intolerance, making it a simple screening tool primarily validated in East Asian populations where the variant is prevalent. Breath acetaldehyde measurement following a controlled alcohol challenge offers a direct assessment of acetaldehyde . Subjects ingest a low dose of (e.g., 0.25-0.5 g/kg or 100 ml of 0.5% solution) after , and breath samples are collected at intervals (e.g., 1-5 minutes post-ingestion) using to quantify acetaldehyde levels. In individuals with deficiency, breath acetaldehyde concentrations are markedly elevated, with medians of 334 ppb for heterozygotes and 537 ppb for homozygotes compared to 96 ppb in wild-type individuals; an acetaldehyde-to- (A/E) ratio cutoff of 23.3 × 10^{-3} achieves 100% and 93% specificity for identifying carriers. This method confirms intolerance by detecting impaired clearance, with levels correlating to the flushing response and other symptoms. Genetic testing directly identifies the ALDH2*2 variant (Glu504Lys) responsible for most cases of inherited alcohol intolerance, using (PCR) or next-generation sequencing on saliva or blood samples. This test detects the (rs671) with high accuracy, confirming deficient activity that leads to accumulation. Since 2023, consumer direct-to-consumer kits from providers like and specialized labs have made this testing more accessible, allowing at-home sample collection and online results for personalized risk assessment. To distinguish genetic intolerance from acquired forms due to liver dysfunction, such as gamma-glutamyl transferase (GGT) and () are performed via blood analysis. Elevated GGT (>50 U/L) and ALT (>40 U/L) levels suggest alcohol-related as a potential cause of secondary intolerance, whereas normal results support a primary genetic by ruling out hepatic . These enzymes rise in response to or heavy alcohol exposure, providing context for intolerance symptoms without indicating the genetic basis alone.

Differential Diagnosis

Alcohol intolerance must be differentiated from true alcohol allergy, which is a rare to or components in alcoholic beverages, such as grains, , or preservatives, manifesting with symptoms like , , or shortly after exposure. In contrast, alcohol intolerance is a non-immune primarily due to deficient 2 (ALDH2) activity, leading to accumulation and symptoms such as facial flushing, , and nausea without involvement of . Diagnostic distinction often relies on clinical history and testing; for instance, elevated levels during an acute reaction support an allergic or mast cell-mediated process, while for ALDH2 variants or measurement of levels confirms intolerance. Sulfite sensitivity, another common mimic, arises from adverse reactions to sulfites used as preservatives in wines and some beers, particularly affecting individuals with and causing bronchospasm, wheezing, or urticaria rather than the vasodilatory flushing central to alcohol intolerance. Unlike the enzymatic defect in alcohol intolerance, sulfite reactions involve non-IgE-mediated , and symptoms are more respiratory-focused, helping to differentiate them through challenge tests or exclusion of sulfite-containing beverages. Conditions like should be ruled out in cases of recurrent flushing triggered by alcohol, as this disorder releases vasoactive substances such as serotonin, leading to episodic flushing often accompanied by , wheezing, or pellagra-like skin changes. Similarly, disorders, including systemic and , can present with alcohol-induced flushing due to release, but typically include additional features like pruritus, , or gastrointestinal upset, with diagnosis supported by persistently elevated baseline serum levels. According to a 2024 update on flushing evaluation, biomarkers play a key role: urinary (5-HIAA) or serum chromogranin A for , versus for disorders and assays for intolerance, ensuring accurate exclusion of these serious mimics.

Management

Preventive Strategies

The primary preventive strategy for alcohol intolerance is complete from consumption, as even small amounts can lead to the accumulation of toxic and trigger symptoms such as facial flushing, , and rapid heartbeat due to genetic or acquired deficiencies in alcohol-metabolizing enzymes. This approach eliminates the risk of episodes entirely and is recommended by major medical organizations for individuals diagnosed with the condition. In social settings where is prevalent, harm reduction measures include substituting alcoholic beverages with non-alcoholic alternatives, such as mocktails, non-alcoholic beer, or flavored sparkling waters, which allow participation in rituals without exposure to . Genetic counseling is advised for carriers of ALDH2 deficiency variants, particularly the common rs671 prevalent in East Asian populations, to assess personal risks and inform lifestyle choices. Counseling sessions typically cover the autosomal dominant inheritance pattern and emphasize the importance of alcohol avoidance to mitigate health risks like and . For , implications include heightened fetal risks from maternal alcohol exposure in ALDH2-deficient individuals, as the variant may exacerbate developmental issues in offspring; complete abstinence during is strongly recommended based on studies showing increased odds of adverse outcomes. These discussions align with ethical guidelines for genetic analysis, such as Japan's Ministry of Health, Labor, and Welfare standards, which prioritize , non-discrimination, and family education in genomic testing. Public health campaigns in high-prevalence regions, such as where up to 50% of the population carries the , focus on raising awareness of genetic alcohol sensitivity to promote reduced consumption and prevent related diseases. Public health campaigns in high-prevalence regions, such as , and some Southeast Asian countries have adopted alcohol warning labels on health risks as part of broader WHO-aligned initiatives. These efforts, including educational materials on implications, aim to shift cultural norms around drinking and encourage early genetic screening.

Symptomatic Treatments

Symptomatic treatments for alcohol intolerance primarily focus on alleviating acute reactions such as flushing, , and following alcohol consumption, though complete avoidance remains the cornerstone of management. Over-the-counter H1-antihistamines, such as loratadine, can help mitigate symptoms like facial flushing, itching, or in minor cases by blocking histamine-mediated responses. A typical dose is 10 mg taken orally once daily, often preemptively before potential exposure to alcohol, though this is an and efficacy varies. For gastrointestinal symptoms like or upset, antacids or inhibitors (PPIs) may provide relief by neutralizing acid or reducing its production, respectively; examples include over-the-counter options like famotidine (an H2-blocker often used similarly for flushing) at 20 mg taken 30-60 minutes prior to drinking. In more severe instances involving rapid (), beta-blockers such as may be prescribed under medical supervision to control , particularly if symptoms mimic those in alcohol sensitivity reactions, but this is not routinely recommended for intolerance alone. Experimental approaches targeting the underlying enzyme deficiency, such as (ALDH2) activators, are under investigation to enhance metabolism and reduce symptoms. Preclinical studies and early human trials suggest potential benefits; for instance, a 2024 open-label study on a containing ALDH demonstrated reduced peak and levels, alleviating related symptoms in healthy participants by approximately 20-30% compared to alcohol alone. However, these remain investigational, with no approved therapies yet, and phase II data are limited. A critical concern with symptomatic treatments is that they may mask discomfort, encouraging increased alcohol intake and heightening risks of , liver damage, or alcohol use disorder, as acetaldehyde accumulation persists despite reduced perceptible symptoms. Individuals should consult healthcare providers before using any medications, as interactions with alcohol can exacerbate effects, and emergency care is advised for severe reactions like difficulty breathing or persistent .

Prognosis

Individuals with alcohol intolerance generally experience a benign when they adhere to alcohol avoidance, as symptoms resolve promptly upon cessation of consumption and do not progress to conditions in the absence of . Complete eliminates the immediate adverse reactions, such as flushing and , allowing for normal daily functioning without long-term deterioration. However, persistent alcohol consumption despite intolerance elevates cancer due to acetaldehyde accumulation, a known ; a 2023 meta-analysis of cohort studies in East Asian populations with ALDH2 variants estimated that -attributable cancers, including esophageal and liver types, are underestimated by up to 30% in affected drinkers compared to general estimates. This heightened vulnerability underscores the importance of compliance, as even moderate intake can amplify for upper aerodigestive tract malignancies by factors of 2 to 4 in genetically susceptible individuals. Complications like may further influence prognosis if intolerance is ignored, potentially reducing in non-abstinent cases. Education on alcohol intolerance enhances functioning by promoting and reducing , enabling individuals to navigate social settings more confidently without pressure to drink. Nonetheless, persists in cultures with heavy drinking norms, where non-participation in alcohol consumption can lead to or perceptions of deviance, exacerbating psychological distress. Acquired forms of alcohol intolerance, such as those induced by medications like exhibiting disulfiram-like effects, are often reversible upon discontinuation of the offending agent, with symptoms typically resolving within days to weeks as metabolic pathways normalize. The outlook for inherited cases may improve through emerging approaches; preclinical studies using AAVrh.10hALDH2 vectors in ALDH2-deficient mouse models demonstrate restoration of enzyme function and alleviation of toxicity, hinting at potential future interventions for ALDH2 .

References

  1. [1]
    Alcohol Intolerance: Symptoms, Tests & Alcohol Allergy
    Alcohol intolerance causes uncomfortable symptoms after drinking a small amount of alcohol. Avoiding alcohol can help eliminate symptoms.
  2. [2]
    Alcohol sensitivity, acute (Concept Id: C2674838) - NCBI
    Alcohol intolerance is characterized by immediate unpleasant reactions after drinking alcohol. The most common signs and symptoms of alcohol intolerance are ...
  3. [3]
    Alcohol Flush Reaction: Does Drinking Alcohol Make Your Face Red?
    The primary feature of the alcohol flush reaction is a red face—or flush—but it can also be accompanied by hives, nausea, low blood pressure, the worsening of ...
  4. [4]
    Alcohol Intolerance: What You Need to Know - Cedars-Sinai
    Nov 3, 2023 · Between 30%-50% of people of East Asian descent have alcohol intolerance, a fact which leads many to refer to the condition as “Asian flush” or ...
  5. [5]
    Alcohol intolerance - Symptoms & causes - Mayo Clinic
    Alcohol intolerance is a genetic condition in which the body can't break down alcohol efficiently. Alcohol intolerance can cause immediate reactions after ...Overview · When to see a doctor · Causes
  6. [6]
    Allergic and intolerance reactions to wine - PMC - NIH
    Hypersensitivity reactions due to alcoholic drinks, mainly in the form of airway reactions (rhinitis and asthma), occur significantly more frequently in persons ...
  7. [7]
    Genetic Influences Affecting Alcohol Use Among Asians - PMC
    People with two copies of the defective gene respond to alcohol consumption with intense flushing and other unpleasant reactions, such as nausea. Consequently, ...
  8. [8]
    The Alcohol Flushing Response: An Unrecognized Risk Factor for Esophageal Cancer from Alcohol Consumption
    ### Summary of Odds Ratios for Esophageal Cancer in ALDH2 Deficiency Carriers Related to Alcohol Consumption
  9. [9]
    Esophageal motor disorder in alcoholics - PubMed - NIH
    Both acute and chronic ethanol consumption may cause esophageal dysmotility. In order to systematically evaluate the effect of ethanol on esophageal motility ...Missing: intolerance | Show results with:intolerance
  10. [10]
    Risks of substance uses, alcohol flush response, Helicobacter pylori ...
    Apr 18, 2019 · We found that the presence of facial flushing after drinking alcohol was the significant risk for reflux esophagitis and Barrett's esophagus.
  11. [11]
    Genetic variant that inhibits alcohol metabolism linked to increased ...
    Jan 25, 2023 · A genetic variant that inhibits alcohol metabolism and can leave some people with a reddened complexion is linked to blood vessel damage and an increased risk ...
  12. [12]
    Alcohol, IgE and allergy - PubMed
    Alcoholic drinks are involved in a variety of hypersensitivity reactions. These include flushing syndrome, anaphylactoid reactions (urticaria/angioedema and ...<|separator|>
  13. [13]
    Primary Reason for Drinking Among Current, Former, and Never ...
    Jan 13, 2019 · Alcohol consumption among individuals who experience a flushing response (reddening of the face, nausea, dizziness, headache, anxiety, ...
  14. [14]
    ALCOHOL METABOLISM - PMC - PubMed Central - NIH
    The goal of this Review is to describe the pathways responsible for the metabolism of alcohol (ethanol) and understand the factors which regulate this ...
  15. [15]
    Alcohol Metabolism in the Progression of Human Nonalcoholic ... - NIH
    Over 90% of consumed alcohol is metabolized through the oxidative pathways that are mediated by alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) ( ...
  16. [16]
    Alcohol and Acetaldehyde in Public Health: From Marvel to Menace
    Mar 25, 2010 · Moreover, the acetaldehyde-DNA binding has been considered to promote carcinogenesis in alcohol-dependent individuals [111]. Similarly, ...
  17. [17]
    Overview: How Is Alcohol Metabolized by the Body? - PubMed Central
    Class I ADH and ALDH2 play a central role in alcohol metabolism. Variations in the genes encoding ADH and ALDH produce alcohol-and acetaldehyde-metabolizing ...
  18. [18]
    Alcohol and aldehyde dehydrogenase - PubMed - NIH
    The Km-values for ethanol of ADH isoenzymes relevant for alcohol degradation range from 49 microM to 36 microM, and the Vmax-values from 0.6 to 10 U/mg.
  19. [19]
    The Genetics of Alcohol Metabolism - NIH
    Studies have shown that people carrying certain ADH and ALDH alleles are at significantly reduced risk of becoming alcohol dependent.Gene Structure And Gene... · Adh Genes And Their... · Aldh Genes And Their...
  20. [20]
    Alcohol Metabolizing Enzymes, Microsomal Ethanol Oxidizing ...
    ALDH enzymes use NAD+ as a cofactor ... Increasing intracellular NADH levels secondary to ethanol metabolism from ADH and ALDH inhibit fatty acid oxidation [112].
  21. [21]
    A common East-Asian ALDH2 mutation causes metabolic disorders ...
    Sep 25, 2023 · This mutation results in a reduction of the ALDH2 enzymatic activity by 60–80% in heterozygous carriers and ~90% in homozygous carriers. People ...
  22. [22]
    ADH1B - an overview | ScienceDirect Topics
    The ADH1B*2 and ALDH2 *2 alleles raise the levels of acetaldehyde by increasing the rate of synthesis and decreasing the rate of metabolism, respectively ...
  23. [23]
    ALDH2 and ADH1B Interactions in Retrospective Reports of Low ...
    An interaction was found between ALDH2*2 and ADH1B*2, with ADH1B*2 being associated with heightened self-reported sensitivity to alcohol only in individuals who ...Missing: compound | Show results with:compound
  24. [24]
    Positive selection acts on regulatory genetic variants in populations ...
    Mar 16, 2022 · ... alcohol dependent. This, then, could lead to increased methylation of the ALDH2 promoter, resulting in decreased ALDH2 gene expression.
  25. [25]
    Alcohol Metabolism and Epigenetics Changes - PubMed Central - NIH
    The effects of alcohol metabolism on histone acetylation have been demonstrated in animal experiments, including studies of obese mice.
  26. [26]
    Multi-ancestry study of the genetics of problematic alcohol use in ...
    Dec 7, 2023 · There has been substantial progress made in genome-wide association studies (GWAS) of AUD and related phenotypes, including measures of alcohol ...Missing: intolerance ADH7
  27. [27]
    Rare and common variants associated with alcohol consumption ...
    Jun 21, 2024 · The shared network identified gene families that function in alcohol metabolism, including ADH, ALDH, CYP, and UGT.Missing: intolerance ADH7
  28. [28]
    ALDH2 polymorphism and alcohol-related cancers in Asians
    Mar 3, 2017 · Many studies have demonstrated the protective effect against alcohol addiction and abuse by ALDH2 deficiency.
  29. [29]
    Racial differences in alcohol sensitivity - PubMed
    The existence of racial differences in alcohol sensitivity between Oriental and Caucasian populations has been well documented.<|control11|><|separator|>
  30. [30]
    Molecular basis of difference in alcohol metabolism ... - Nature
    According to Wolff (1972, 1973), more than 80% of Orientals are alcohol sensitive, while only 5~ of Caucasians respond abnormally after alcohol administration. ...
  31. [31]
    Are Women Who Drink More at Risk Than Men? - Mount Sinai Today
    Sep 13, 2024 · Women have lower levels of ADH, meaning they have less ability to metabolize that alcohol. So bottom line, the alcohol hangs around longer and ...Missing: intolerance | Show results with:intolerance
  32. [32]
    Alcohol and sickness: Intolerance signs, causes, and aging
    Sep 22, 2023 · Signs of alcohol intolerance · facial redness or flushing, referred to as the alcohol flush reactionTrusted Source · skin issues, such as itchy ...
  33. [33]
    Alcohol and age: A risky combination - Harvard Health
    Jan 27, 2018 · Your ability to metabolize alcohol declines. After drinking the same amount of alcohol, older people have higher blood alcohol concentrations ...
  34. [34]
    Alcohol - World Health Organization (WHO)
    Jun 28, 2024 · Of this, 209 million people (3.7% of the adult world population) lived with alcohol dependence. Alcohol consumption, even at low levels can ...
  35. [35]
    Addressing alcohol consumption and socioeconomic inequalities
    Mar 21, 2022 · Alcohol consumption accounts for about 5% of the global burden of diseases but is unequally distributed across socioeconomic groups.
  36. [36]
    Novel and prevalent non-East Asian ALDH2 variants - NIH
    May 8, 2020 · As expected, the ALDH2*2 (E504K) variant is the most prevalent genetic variant worldwide, with an allele frequency of 26.6% among East Asians, ...
  37. [37]
    Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and ...
    Jan 4, 2021 · In the Chinese Han population, the ALDH2*2 allele frequency is 17% to 29%, the proportion of individuals with ALDH2*1/*2 heterozygotes is 36% ...
  38. [38]
    Population history in Okinawa based on JC virus and ALDH2 ...
    Apr 30, 2020 · The ALDH2 variant arose about 2,000–3,000 years ago in the Chinese population. The frequency of the ALDH2 variant is 31.9% in the Japanese ...
  39. [39]
    ALDH2 variance in disease and populations - PMC - NIH
    Jun 24, 2022 · The dysfunctional ALDH2 variant affects nearly 8% of the world population and is highly concentrated among East Asians.
  40. [40]
    Molecular adaption of alcohol metabolism to agriculture in East Asia
    Dec 28, 2016 · The study on the micro-evolution of alcohol metabolic genes will help us understand how human adapted to the artificial environment of agriculture.
  41. [41]
    Contribution of infectious diseases to the selection of ADH1B and ...
    Mar 10, 2024 · The two variants ADH1B*2 and ALDH2*2 are strongly associated with alcohol sensitivity in East Asian subjects. Combining available data on ...
  42. [42]
    ALDH2 variance in disease and populations
    Jun 24, 2022 · The dysfunctional ALDH2 variant affects nearly 8% of the world population and is highly concentrated among East Asians.
  43. [43]
    Functional variants in ADH1B and ALDH2 are non-additively ...
    Sep 26, 2019 · These alleles are common among East Asians (frequency = 0.738 and 0.255), but are rare or at low frequency in other populations (frequency = 0. ...
  44. [44]
    Alcohol intolerance in East Asians - UCSC Genome Browser
    ALCOHOL INTOLERANCE IN EAST ASIAN POPULATIONS. Ethanol, also known as ... "Latino/Admixed American" populations have the second highest frequency (0.1 ...
  45. [45]
    Uncovering genetic mechanisms associated with harmful use of ...
    Jul 7, 2025 · Variants at 1p33 are potentially involved in the harmful use of alcohol in an admixed Latin American population. Furthermore, our results ...
  46. [46]
    [PDF] Toxicological Profile for Carbon Disulfide
    The ATSDR toxicological profile succinctly characterizes the toxicologic and adverse health effects information for these toxic substances described therein ...
  47. [47]
    Carbon Disulfide Toxicity - StatPearls - NCBI Bookshelf
    Jun 21, 2025 · Countries with active rayon and chemical industries, such as China, India, and regions of Southeast Asia, continue to report occupational ...
  48. [48]
    ALDH2, ADH1B, and ADH1C Genotypes in Asians - PubMed Central
    The purpose of this article is to review genotype 1 prevalence rates of three genes, the aldehyde dehydrogenase gene ALDH2 and the alcohol dehydrogenase genes ...
  49. [49]
    Genetic influences on alcohol flushing in East Asian populations - NIH
    The decrease in heritability supports the role of ALDH2 and ADH1B as major contributors to the self-reported alcohol flushing response in the Chinese and Korean ...
  50. [50]
    Genetic influences on alcohol flushing in East Asian populations
    Oct 24, 2023 · SNP-based heritability analyses estimated that around 13% of the phenotypic variation in flushing is explained by common genetic variants. The ...
  51. [51]
    Polygenic risk for alcohol use disorder affects cellular responses to ...
    Nov 8, 2024 · This study provides insights into the intricate relationship between AUD PRS, ethanol, and microglial function, potentially influencing neuronal functions in ...
  52. [52]
    A high-resolution PheWAS approach to alcohol-related polygenic ...
    Jan 17, 2024 · This study uses a high-resolution phenome-wide approach to evaluate the motivational mechanisms of polygenic risk scores (PRSs) that have been robustly ...
  53. [53]
    Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde ...
    Sjögren-Larsson syndrome (SLS) is an inherited disorder associated with impaired fatty alcohol oxidation due to deficient activity of fatty alcohol:NAD+ ...
  54. [54]
    Sjögren-Larsson syndrome. Impaired fatty alcohol oxidation in ... - JCI
    These results suggest that the primary defect in SLS is deficiency of fatty alcohol:NAD+ oxidoreductase. SLS represents the first inherited disorder in man ...
  55. [55]
    Alcohol-Related Liver Disease: Basic Mechanisms and Clinical ...
    As mentioned earlier, chronic alcohol use upregulates CYP2E1 production, which leads to increased acetaldehyde concentration, diminished ALDH activity, and ...
  56. [56]
    Alcohol-associated liver disease: A review - ScienceDirect.com
    Prolonged high alcohol intake, more likely than the former, can lead to alcoholic hepatitis, characterised by hepatic inflammation and liver cell damage.
  57. [57]
    Disulfiram and metronidazole Interactions - Drugs.com
    The presumed mechanism is inhibition of aldehyde dehydrogenase (ALDH) by metronidazole in a manner similar to disulfiram. Following ingestion of alcohol, ...
  58. [58]
    Disulfiram-like Reaction With Metronidazole: An Unsuspected Culprit
    Conclusion. The concomitant use of alcohol-containing medications with metronidazole may cause serious adverse reactions and discomfort for the patient.
  59. [59]
    Alcohol intolerance associated with Hodgkin lymphoma - PMC - NIH
    The differential diagnosis of alcohol intolerance includes Hodgkin lymphoma, carcinoid syndrome and mutations of the gene encoding alcohol dehydrogenase 2 (most ...Missing: endocrine | Show results with:endocrine
  60. [60]
    Pathophysiology of the Effects of Alcohol Abuse on the Endocrine ...
    Alcohol abuse disrupts all of these systems and causes hormonal disturbances that may result in various disorders, such as stress intolerance, reproductive ...
  61. [61]
    Host ALDH2 deficiency aggravates acetaldehyde metabolism ...
    This study aimed to investigate the effect of 5% v/v alcohol exposure on the gut microbiota of ALDH2 knockout (KO-5%) and wild-type (WT-5%) mice.
  62. [62]
    Alcohol-induced gut permeability defect through dysbiosis and ...
    Apr 27, 2025 · Both low- and high-dose alcohol induced leaky gut, while only the high-dose caused gut dysbiosis and alcohol damaged mitochondria but enhanced glycolysis in ...
  63. [63]
    The Role of CYP2E1 in Alcohol Metabolism and Sensitivity in the ...
    Induction of CYP2E1 in the CNS by nicotine likely increases the metabolism of ethanol to acetaldehyde, a result consistent with the theory that increases in CNS ...
  64. [64]
    The Role of CYP2E1 in the Drug Metabolism or Bioactivation in the ...
    Jan 10, 2017 · Tobacco smoke has been shown to have greater ethanol metabolism rates and to induce the ethanol metabolizing enzyme CYP2E1 in animals and humans ...
  65. [65]
    Epidemiologic relationship between alcohol flushing and smoking in ...
    Jul 8, 2024 · The odds of experiencing alcohol flushing were 91.3% higher in the current smokers with ≥ 20 PYs than in the non-smokers (95% CI 1.38–2.654 for ...
  66. [66]
    Histamine and histamine intolerance - ScienceDirect.com
    The ingestion of histamine-rich food or of alcohol or drugs that release histamine or block DAO may provoke diarrhea, headache, rhinoconjunctival symptoms, ...
  67. [67]
    Histamine Intolerance: Symptoms, Diagnosis, and Beyond - PMC - NIH
    Apr 19, 2024 · These foods include seafood, fermented soybean products, aged cheese, avocado, chocolate, nuts, milk, legumes, and fruits like bananas [19,21].
  68. [68]
    Dimethylformamide and alcohol intolerance - PMC - NIH
    The highest recorded concentration of DMF in air was 200 ppm. The DMF-ethanol reaction is possibly attributable to the inhibition of acetaldehyde metabolism, ...
  69. [69]
    Dimethylformamide (EHC 114, 1991) - Inchem.org
    Exposure to DMF, even at concentrations below 30 mg/m3, may cause alcohol intolerance. Symptoms may include a sudden facial flush, tightness in the chest, and ...
  70. [70]
    Differential effects of acute versus chronic stress on ethanol sensitivity
    Pharmacokinetics and corticosterone sensitivity to ethanol were unaffected by stress. Chronic stress increased sensitivity to ethanol-induced hypnosis.
  71. [71]
    Heightened Sensitivity to the Disinhibiting Effect of Alcohol in ...
    The findings of this study demonstrate that around ovulation, women exhibit increased disinhibition while intoxicated.Missing: intolerance | Show results with:intolerance
  72. [72]
    Alcohol intolerance testing
    Oct 17, 2024 · It is possible to determine ALDH2 function via acetaldehyde breath testing or by ethanol patch testing.
  73. [73]
    Establishment of a Quick and Highly Accurate Breath Test for ... - NIH
    Jun 8, 2017 · We showed that breath acetaldehyde levels after alcohol ingestion in carriers of the ALDH2*2 allele were significantly higher than those in ...
  74. [74]
  75. [75]
    Alcohol patch test with hue-saturation-value model analysis predicts ...
    The alcohol patch test (APT) can detect aldehyde dehydrogenase (ALDH) genetic polymorphisms used to diagnose cutaneous erythema.
  76. [76]
    Ethanol patch test--a simple and sensitive method for ... - PubMed
    The ethanol patch test, which is considered to be a cutaneous model of flushing, was performed on 311 healthy Japanese (237 adults and 74 children).
  77. [77]
    ALCOHOL INTOLERANCE - Medicover Genetics
    Carrier Screening Core Panel analyzes 19 genes associated with genetic diseases of high incidence and severity in individuals with unknown carrier status.Missing: prevalence | Show results with:prevalence
  78. [78]
    Uncovering newly identified aldehyde dehydrogenase 2 genetic ...
    Jul 29, 2024 · After IRB approval, human subjects were given an alcohol challenge (0.25 g/kg) while quantifying acetaldehyde levels and the physiological ...Missing: intolerance | Show results with:intolerance
  79. [79]
  80. [80]
    DNA Alcohol Intolerance Test | Genex Diagnostics
    14-day returnsA simple mouth swab is all we need to find out whether you have inherited DNA changes that affect your ability to metabolize alcohol.
  81. [81]
    Gamma-Glutamyl Transferase (GGT) Blood Test - Cleveland Clinic
    Don't consume any alcohol for at least 24 hours before the test. Even small amounts of alcohol can increase your GGT levels. What happens during a GGT test?Overview · Test Details · Results And Follow-Up
  82. [82]
    Assessing alcohol intake & its dose-dependent effects on liver ... - NIH
    Our results support previous findings that GGT is a more sensitive indicator of moderate levels of alcohol consumption than AST and ALT [12, 13, 16]. Elevated ...Estimates Of Alcohol Intake · Statistical Analysis · Table 5
  83. [83]
    Biomarkers of Liver Status in Heavy Drinkers, Moderate Drinkers ...
    In heavy drinkers, serum GGT, AST, ALT, ferritin and albumin were all significantly higher than in moderate drinkers or abstainers.
  84. [84]
    Approach to flushing in adults - UpToDate
    Apr 11, 2024 · Outline · - Rosacea · - Medications · - Food ingestion · - Alcohol · - Carcinoid syndrome · - Mastocytosis · - Pheochromocytoma · - Medullary thyroid ...
  85. [85]
    Alcohol Allergies and Intolerance - Verywell Health
    Feb 9, 2024 · Sulfites naturally found in wine and beer can cause asthma symptoms in people who are sensitive to sulfites. In rare cases, a reaction can be ...Gluten Sensitivity · Histamine Intolerance · Sulfite Allergies · Yeast Allergies
  86. [86]
    Carcinoid syndrome - Symptoms & causes - Mayo Clinic
    Flushing may happen for no obvious reason, though sometimes it can be triggered by stress, exercise or drinking alcohol. Facial skin lesions. Purplish areas ...
  87. [87]
    Systemic mastocytosis - Symptoms and causes - Mayo Clinic
    Nov 20, 2020 · Flushing, itching or hives; Abdominal pain, diarrhea, nausea or ... Alcohol; Skin irritation; Spicy foods; Exercise; Insect stings; Certain ...
  88. [88]
    10 alternative alcoholic drinks - MedicalNewsToday
    Mar 28, 2023 · Alternatives to drinking alcohol include nonalcoholic beer or wine, mocktails, and kombucha. Experts associate alcohol with a range of health ...Missing: intolerance | Show results with:intolerance<|separator|>
  89. [89]
    Impact of the aldehyde dehydrogenase 2 (ALDH2) gene testing on ...
    May 7, 2025 · It is hypothesized that ALDH2 gene testing may reduce alcohol consumption and the incidence of alcohol-associated disorders among unhealthy alcohol users.
  90. [90]
    Role of ADH1B and ALDH2 gene polymorphisms—The Yamanashi
    Oct 22, 2024 · Conclusions: Our results suggest that alcohol consumption by pregnant females car- rying the deficient variant ALDH2*2 genotype may increase the ...
  91. [91]
    Effectiveness of genetic feedback on alcohol metabolism to reduce ...
    May 20, 2024 · This study aimed to examine the effects of a brief intervention based on the screening of ALDH2 and ADH1B gene polymorphisms on alcohol consumption in Japanese ...<|control11|><|separator|>
  92. [92]
    MAOIs and diet: Is it necessary to restrict tyramine? - Mayo Clinic
    Jan 31, 2025 · Generally, foods high in tyramine are those that are aged, fermented, overripe or spoiled. You'll likely need to stay on a low-tyramine diet until a few weeks ...
  93. [93]
    Adoption of Alcohol Health Warning Labels (AHWLs) across South ...
    The adoption of the AHWLs across the South East Asian countries is variable. There is a need to invest in identification of evidence based AHWLs.Missing: campaigns | Show results with:campaigns
  94. [94]
    Health warning labels on alcoholic beverages in the WHO European ...
    May 23, 2024 · Health warning labels on alcoholic beverages in the WHO European Region in 2024. 23 May 2024. | Technical document. Health warning labels on ...Missing: public | Show results with:public
  95. [95]
    Alcohol intolerance - Diagnosis & treatment - Mayo Clinic
    Diagnosis · Skin test. A skin test can show whether you might have an allergy to something in alcoholic beverages, for example, the grains in beer. · Blood test.
  96. [96]
    Loratadine - StatPearls - NCBI Bookshelf
    Mar 13, 2023 · In adolescents, adults, and geriatrics: 10 mg by mouth daily or 5 mg twice daily; do not exceed 10 mg in 24 hours. In pediatrics, at ages 2 to 5 ...
  97. [97]
    Antihistamines prevent 'Asian flush' but with huge risks - HSC News
    Dec 21, 2016 · Using histamine-2 blockers to reduce the 'Asian flush' can escalate alcohol intake and increase the risk of stomach cancers, esophageal cancer and a type of ...Missing: GERD | Show results with:GERD
  98. [98]
    A new strategy for the treatment of alcohol use disorders - PubMed
    There is now preclinical evidence supporting the use of activators of ALDH2 as a pharmacological strategy for the treatment of AUD.Missing: trial intolerance
  99. [99]
    A Compound Containing Aldehyde Dehydrogenase Relieves the ...
    Oct 12, 2025 · KISLip® significantly reduced the highest level (Cmax) of alcohol and overall levels of acetaldehyde compared to the alcohol-only group in a ...
  100. [100]
    ALDH2 polymorphism, alcohol intake and the attributable burden of ...
    Jun 1, 2023 · The burden of liver, esophageal, and oral cavity/pharynx cancer attributable to alcohol is underestimated in populations with the ALDH2 genetic polymorphism.Missing: deficiency intolerance cohort
  101. [101]
    Alcohol and Cancer Risk Fact Sheet - NCI
    May 2, 2025 · Can drinking red wine help prevent cancer ... The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol ...Missing: flags referral
  102. [102]
    Psychologists are tackling the hidden epidemic of excessive alcohol ...
    Jun 1, 2023 · Cultural beliefs paint alcohol use disorder as black and white, a mindset that often means too few people get help for problematic drinking.
  103. [103]
    Why stigma matters in addressing alcohol harm - Wiley Online Library
    Apr 12, 2023 · Alcohol stigma encompasses widely endorsed negative stereotypes leading to prejudice and discrimination towards people with alcohol use disorder.
  104. [104]
    Drug-Associated Alcohol Intolerance: A Real-World ... - NIH
    Jun 27, 2025 · This study highlights significant associations between several medications and alcohol intolerance, emphasizing the need for further research to confirm these ...Missing: iatrogenic | Show results with:iatrogenic
  105. [105]
    Gene Therapy Correction of Aldehyde Dehydrogenase 2 Deficiency
    ALDH2*2 heterozygotes have increased risk for upper digestive tract cancers, compounded by smoking and drinking alcohol. We hypothesized that a one-time ...